Skyward Specialty Insurance
SKWD
64.43
+0.89
+1.40%
Skyward Specialty Insurance
US · SKWD
#2644 by market cap
Listed 2023
64.43
+0.89
+1.40%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Recent news
-
Rating change
Skyward Specialty Insurance Group, Inc. (SKWD) Receives a Buy From BarclaysTipRanks · 2026/10/7
-
Rating change
Analysts Offer Insights on Financial Companies: Skyward Specialty Insurance Group, Inc. (SKWD) and Hiscox (OtherHCXLF)TipRanks · 2026/8/6
-
Rating change
KBW Maintains Skyward Specialty Insurance(SKWD.US) With Buy Rating, Raises Target Price to $78Market Newswire · 2026/10/13
-
Rating change
Analysts Offer Insights on Financial Companies: Pinnacle Financial Partners (PNFP), Affirm Holdings (AFRM) and Skyward Specialty Insurance Group, Inc. (SKWD)TipRanks · 2026/8/5
-
Rating change
William Blair Maintains Skyward Specialty Insurance(SKWD.US) With Buy RatingMarket Newswire · 2026/8/6
-
Rating change
TD Cowen Maintains Skyward Specialty Insurance(SKWD.US) With Hold Rating, Raises Target Price to $65Market Newswire · 2026/8/11
-
Barclays Maintains Skyward Specialty Insurance(SKWD.US) With Buy Rating, Raises Target Price to $71Market Newswire · 2026/11/6
-
Analysts Offer Insights on Financial Companies: Skyward Specialty Insurance Group, Inc. (SKWD) and Lemonade (LMND)TipRanks · 2026/10/12
-
Rating change
Analysts Conflicted on These Financial Names: Sixth Street Specialty Lending (TSLX), Enact Holdings (ACT) and Skyward Specialty Insurance Group, Inc. (SKWD)TipRanks · 2026/8/10
-
Truist Financial Maintains Skyward Specialty Insurance(SKWD.US) With Buy Rating, Maintains Target Price $75Market Newswire · 2026/10/2
-
Rating change
Truist Financial Maintains Skyward Specialty Insurance(SKWD.US) With Buy Rating, Announces Target Price $75Market Newswire · 2026/8/6
-
Rating change
Barclays Maintains Skyward Specialty Insurance(SKWD.US) With Buy Rating, Maintains Target Price $68Market Newswire · 2026/10/7
-
Rating change
KBW Maintains Skyward Specialty Insurance(SKWD.US) With Buy Rating, Raises Target Price to $75Market Newswire · 2026/8/10
-
Rating change
Truist Financial Maintains Skyward Specialty Insurance(SKWD.US) With Buy RatingMarket Newswire · 2026/8/5
-
Rating change
Analysts Have Conflicting Sentiments on These Financial Companies: Western Union (WU) and Skyward Specialty Insurance Group, Inc. (SKWD)TipRanks · 2026/10/2
-
Rating change
Analysts Offer Insights on Financial Companies: Assurant (AIZ), Upstart Holdings (UPST) and Skyward Specialty Insurance Group, Inc. (SKWD)TipRanks · 2026/8/5
-
Rating change
Barclays Maintains Skyward Specialty Insurance(SKWD.US) With Buy Rating, Raises Target Price to $68Market Newswire · 2026/8/5
-
Piper Sandler Maintains Skyward Specialty Insurance(SKWD.US) With Buy Rating, Maintains Target Price $72Market Newswire · 2026/11/6
-
KBW Maintains Skyward Specialty Insurance(SKWD.US) With Buy Rating, Raises Target Price to $79Market Newswire · 2026/11/11
-
Rating change
Analysts Offer Insights on Financial Companies: Skyward Specialty Insurance Group, Inc. (SKWD), American International Group (AIG) and GCM Grosvenor (GCMG)TipRanks · 2026/8/11
-
Published on 10/09: SKWD Shows Bullish Continuation Wedge, as Skyward Specialty to Release Q3 2026 Results Post-market on Nov. 5Market Newswire · 2026/10/9
-
Rating change
Piper Sandler Maintains Skyward Specialty Insurance(SKWD.US) With Buy Rating, Maintains Target Price $72Market Newswire · 2026/8/24
-
Rating change
Barclays Sticks to Its Buy Rating for Skyward Specialty Insurance Group, Inc. (SKWD)TipRanks · 2026/8/5
-
Rating change
Skyward Specialty Insurance Group, Inc. (SKWD) Initiated With a Buy at William O'NeilTipRanks · 2026/7/22
-
Rating change
Piper Sandler Maintains Skyward Specialty Insurance(SKWD.US) With Buy Rating, Raises Target Price to $72Market Newswire · 2026/7/15
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:02:26 · For reference only, not investment advice and not tailored to your situation.
Skyward Specialty Insurance discussion 0 comments